Want to see IN:LOTUSEYE full AI Analyst Report?

Lotus Eye Hospital And Institute Ltd (LOTUSEYE) Price & Analysis

0 Followers

LOTUSEYE Stock Chart & Stats

₹118.10

-₹0.92(-1.30%)

At close: Jan 08 4:00 PM EST

₹118.10

-₹0.92(-1.30%)

Day’s Range― - ―

52-Week Range₹71.10 - ₹153.00

Previous CloseN/A

Volume15.88K

Average Volume (3M)2.23K

Market Cap

₹2.46B

Enterprise Value₹2.95B

Total Cash (Recent Filing)₹38.27M

Total Debt (Recent Filing)₹158.34M

Price to Earnings (P/E)3109.5

Beta0.93

Next Earnings

Aug 17, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.04

Shares Outstanding20,796,330

10 Day Avg. Volume4,541

30 Day Avg. Volume2,230

Financial Highlights & Ratios

PEG Ratio-27.83

Price to Book (P/B)3.28

Price to Sales (P/S)3.68

P/FCF Ratio-18.58

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Integrated Ophthalmology Business ModelLotus Eye’s focused, vertically integrated ophthalmology model bundles consultations, diagnostics, surgeries and optical sales. That diversified service mix supports recurring patient revenue, stronger lifetime value and referral-driven demand, producing a durable cash-revenue base over months to years.

Consistent Revenue GrowthSteady top-line growth (mid-single-digit year-over-year) indicates persistent demand for clinical and surgical eye-care services. Consistent revenue provides a platform to recover operating leverage if cost pressures are addressed, supporting medium-term operational stability and expansion plans.

Equity-backed Balance SheetA sizable equity base relative to debt gives the company a capital buffer to absorb shocks and fund growth. Even with higher leverage, the equity backing supports access to capital and provides creditors comfort, preserving strategic flexibility for investment or network expansion over the coming quarters.

Bears Say

Deteriorating ProfitabilityMargins have compressed sharply despite revenue growth, signalling structural cost or pricing issues. Negative operating margin erodes the company's ability to fund operations internally, weakens return on invested capital and could make sustaining clinic-level economics difficult without remedial action.

Deeply Negative Free Cash FlowMaterial negative free cash flow indicates operating cash and internal profits are insufficient to fund capex or working capital. Persistent FCF deficits force external financing, constrain reinvestment and elevate liquidity risk, limiting the firm's ability to self-fund growth or withstand shocks.

Rising LeverageRapidly higher leverage increases fixed obligations and reduces financial flexibility, especially given compressed margins and weak cash generation. Rising debt amplifies refinancing and interest-rate exposure, raising the company's vulnerability if profitability and cash flow do not improve.

Lotus Eye Hospital And Institute Ltd News

Lotus Eye Hospital Declares Non-Applicability of SEBI Large Corporate Norms

Lotus Eye Hospital And Institute Ltd ( ($IN:LOTUSEYE) ) just unveiled an update. Lotus Eye Hospital and Institute...

3M ago

Lotus Eye Hospital Fined by BSE, NSE for Governance Non-Compliance

Lotus Eye Hospital And Institute Ltd ( ($IN:LOTUSEYE) ) just unveiled an update. Lotus Eye Hospital and Institute...

4M ago

LOTUSEYE FAQ

What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?

Lotus Eye Hospital And Institute Ltd lowest stock price was ₹71.10 and its highest was ₹153.00 in the past 12 months.

What is Lotus Eye Hospital And Institute Ltd’s market cap?

Lotus Eye Hospital And Institute Ltd’s market cap is ₹2.46B.

When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?

Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date is Aug 17, 2026 which is in 34 days.

How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?

Lotus Eye Hospital And Institute Ltd released its earnings results on May 26, 2026. The company reported -₹0.15 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.15.

Is Lotus Eye Hospital And Institute Ltd overvalued?

According to Wall Street analysts Lotus Eye Hospital And Institute Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Lotus Eye Hospital And Institute Ltd pay dividends?

Lotus Eye Hospital And Institute Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Lotus Eye Hospital And Institute Ltd dividends here

What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?

Lotus Eye Hospital And Institute Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?

Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding.

What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?

Lotus Eye Hospital And Institute Ltd reported an EPS of -₹0.15 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.69%.

Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?

Currently, no hedge funds are holding shares in IN:LOTUSEYE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Lotus Eye Hospital And Institute Ltd

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.